Haloperidol (Compound)

Synonyms:haloperidol, 52-86-8, Haldol, Serenace, Aloperidin, Eukystol, Aloperidol, Serenelfi, Brotopon, Serenase, Dozic, Linton, Einalon S, Aloperidolo, Galoperidol, Halojust, Halopoidol, Ulcolind, Uliolind, Halopal, Keselan, Mixidol, Pernox, Sernas, Sernel, Aldo, Lealgin compositum, Bioperidolo, Sigaperidol, Peluces, 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one, McN-JR-1625, Haloperidolum, Aloperidon, 177716-59-5, 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one, R-1625, NSC 170973, R 1625, 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine, Haloperidol (Haldol), 4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone, 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone, CHEMBL54, Haldol (TN), Haldol Solutab, NSC-170973, NSC-615296, 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone, 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-, 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, MLS000028450, CHEBI:5613, DTXSID4034150, Fortunan, Halosten, 4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, J6292F8L3D, Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-, 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-, NSC170973, NSC615296, CAS-52-86-8, NCGC00015500-10, Aloperidolo [DCIT], Halidol, Halopidol, Pekuces, SMR000058303, Halol, Aloperidolo [Italian], 4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one, Haloperidolum [INN-Latin], DTXCID2014150, Neurodol, Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, CCRIS 1630, HSDB 3093, SR-01000003076, EINECS 200-155-6, NSC 615296, BRN 0331267, Duraperidol, UNII-J6292F8L3D, Epoxy resins, 4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone, gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone, 4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, Picroside-III, Haloperidol, 1, Haloperidol, powder, Prestwick_250, Haloperidol [USAN:USP:INN:BAN:JAN], Spectrum_000861, Tocris-0931, starbld0018801, Opera_ID_446, 4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone, HALOPERIDOL [MI], 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl), 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone, Prestwick0_000115, Prestwick1_000115, Prestwick2_000115, Prestwick3_000115, Spectrum2_001268, Spectrum3_000448, Spectrum4_000570, Spectrum5_000788, HALOPERIDOL [INN], HALOPERIDOL [JAN], Lopac-H-1512, HALOPERIDOL [HSDB], HALOPERIDOL [USAN], Biomol-NT_000035, GTPL86, Probes1_000255, Probes2_000296, H 1512, HALOPERIDOL [VANDF], SCHEMBL8264, HALOPERIDOL [MART.], Lopac0_000583, Oprea1_509923, BSPBio_000130, BSPBio_002096, HALOPERIDOL [USP-RS], HALOPERIDOL [WHO-DD], HALOPERIDOL [WHO-IP], KBioGR_000980, KBioGR_002390, KBioSS_001341, KBioSS_002395, 5-21-02-00377 (Beilstein Handbook Reference), MLS001146904, BIDD:GT0128, DivK1c_000654, SPECTRUM1500325, Haloperidol-[Chlorophenyl-d4], SPBio_001236, SPBio_002069, McM-JR-1625, BPBio1_000144, BPBio1_001231, Haloperidol (JP17/USP/INN), BDBM21398, HMS502A16, KBio1_000654, KBio2_001341, KBio2_002390, KBio2_003909, KBio2_004958, KBio2_006477, KBio2_007526, KBio3_001316, KBio3_002869, LNEPOXFFQSENCJ-UHFFFAOYSA-, HALOPERIDOL [ORANGE BOOK], cMAP_000037, Haloperidol for system suitability, NINDS_000654, AC250, HALOPERIDOL [EP MONOGRAPH], HALOPERIDOL [USP IMPURITY], Haloperidol for peak identification, HMS1568G12, HMS1920D03, HMS2089M15, HMS2091J09, HMS2095G12, HMS2234P08, HMS3261F08, HMS3370H11, HMS3657I13, HMS3712G12, Pharmakon1600-01500325, HALOPERIDOL [USP MONOGRAPH], BCP33202, CHA71659, Haloperidol 1.0 mg/ml in Methanol, STR04750, Tox21_110162, Tox21_300475, Tox21_500583, CCG-36042, CCG-39111, HALOPERIDOLUM [WHO-IP LATIN], NSC757054, STL417208, VESALIUM COMPONENT HALOPERIDOL, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one, AKOS000280660, Tox21_110162_1, AT13670, CS-1971, DB00502, LP00583, NSC-757054, SDCCGSBI-0050565.P005, HALOPERIDOL COMPONENT OF VESALIUM, IDI1_000654, MRF-0000027, QTL1_000042, WLN: T6NTJ A3VR DF& DQ DR DG, NCGC00015500-01, NCGC00015500-02, NCGC00015500-03, NCGC00015500-04, NCGC00015500-05, NCGC00015500-06, NCGC00015500-07, NCGC00015500-08, NCGC00015500-09, NCGC00015500-11, NCGC00015500-12, NCGC00015500-13, NCGC00015500-14, NCGC00015500-15, NCGC00015500-16, NCGC00015500-17, NCGC00015500-19, NCGC00015500-24, NCGC00015500-32, NCGC00016234-01, NCGC00023875-02, NCGC00023875-04, NCGC00023875-05, NCGC00023875-06, NCGC00023875-07, NCGC00023875-08, NCGC00023875-09, NCGC00254503-01, NCGC00261268-01, AC-19691, BH166165, HY-14538, SBI-0050565.P004, Haloperidol decanoate impurity, haloperidol-, SC 170973, AB00052008, EU-0100583, FT-0669100, FT-0669101, FT-0697842, H0912, S1920, SW196557-4, C01814, D00136, VU0239704-10, AB00052008-21, AB00052008-22, AB00052008_23, AB00052008_24, A899749, L000288, Q251347, SR-01000003076-2, SR-01000003076-8, W-105791, BRD-K67783091-001-04-8, BRD-K67783091-001-05-5, BRD-K67783091-003-03-6, HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY], SR-01000003076-11, Z1590789254, Haloperidol, European Pharmacopoeia (EP) Reference Standard, .gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone, HALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY], Haloperidol, United States Pharmacopeia (USP) Reference Standard, .gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone, Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard, Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard

Pubchem:PUBCHEM:3559

Id:828762d4-1eb0-5ae4-9886-89603ef45266

Description:nan